Industry Survey: The Value of Electronic Informed Consent

Signant's 2019 industry survey provides insights relevant in today's clinical trials about how eConsent technology revolutionizes patient engagement.

With 85% of sites reporting improved patient comprehension and 79% seeing better retention rates, eConsent delivers measurable benefits across the research ecosystem.

This comprehensive analysis showcases how sponsors and CROs implement digital consent solutions to enhance protocol understanding, reduce administrative burden, and meet regulatory requirements.

The report also demonstrates how integration with other eClinical systems creates a seamless patient journey from recruitment through study completion, driving better outcomes for all stakeholders.

Download it today to learn how eConsent offers significant operational efficiencies while improving the patient experience.